Potassium Acetate

Summary

Potassium Acetate (CHEMBL1201058) is an approved small molecule (ATC B05XA17).

At a glance

• Status: Approved (max clinical phase 4)
• Modality: Small molecule
• ATC class: B05XA17
• Chemistry: 98.14 Da · C2H3KO2

Identifiers

Drug identity and classification

Field	Value
ChEMBL ID	CHEMBL1201058
Name	Potassium Acetate
Type	Small molecule
Max phase	4
FDA approved	yes
PubChem CID	517044
ChEBI	CHEBI:32029
ATC	B05XA17
Molecular formula	C2H3KO2
Molecular weight	98.14
InChIKey	SCVFZCLFOSHCOH-UHFFFAOYSA-M

SMILES: CC(=O)[O-].[K+]

IUPAC name: potassium acetate

ChEBI definition: A potassium salt comprising equal numbers of potassium and acetate ions

Other ChEBI roles (chemical / environmental): food acidity regulator.

Also known as: Acetic acid, potassium salt, Acetic acid, potassium salt (1:1), E-261, E261, FEMA NO. 2920, INS NO.261, INS-261, INS-261(I), Kali aceticum, Potassium acetate, Potassium acetates

Patent coverage: 147,546 distinct patent families (414,183 SureChEMBL compound mentions), from 1 matched compound structure(s). Mentions count patents naming the compound (not distinct inventions), so promiscuous / reference molecules inflate the mention figure — families are the dedup metric.

Targets

Targets

No target linkage available.

Bioactivity

No ChEMBL bioactivity rows at pChembl ≥ 5 (expected for biologics / antibodies).

Target pathways

No target-pathway data for this drug (no mapped target genes).

Indications & clinical

Indications

0 indication records carry no mapped disease name (EFO/MeSH-only); none shown.

Clinical trials

Total trials: 0.

Clinical evidence (CIViC)

No CIViC predictive evidence (expected for non-precision-medicine drugs).

Pharmacology

Pharmacogenomics

No PharmGKB pharmacogenomic data curated for this drug.

Related molecules

Related molecules

No competitor molecules sharing a primary target (ChEMBL phase ≥2 or PubChem drug-class).